Explore Watchlists Pricing

Fuso Pharmaceutical Industries,Ltd. (4538) Income statement

Market cap

¥19.3B

P/E ratio

13.4x

Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Revenue	44,320	48,581	49,098	47,042	45,752	46,782	45,900	46,074	46,902	49,251	49,632	51,015	55,407	60,563	62,307
Revenue growth (%)	-
Cost of revenue	-	-	-	34,046	33,202	33,532	32,630	32,644	34,101	35,142	36,235	37,275	41,568	44,030	46,312
Gross profit	-	-	-	12,995	12,550	13,249	13,269	13,429	12,801	14,109	13,397	13,740	13,838	16,532	15,995
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	12,199	12,254	12,593	12,471	12,168	11,790	11,760	11,473	11,533	11,874	12,401	13,355
Operating income	-	-	-	796	296	656	798	1,261	1,010	2,351	1,924	2,206	1,964	4,131	2,639
Income before tax	74	3,747	2,741	678	172	642	832	1,279	1,066	2,227	1,996	2,215	1,868	3,780	2,349
Pretax margin (%)	0.2	7.7	5.6	1.4	0.4	1.4	1.8	2.8	2.3	4.5	4	4.3	3.4	6.2	3.8
Provision for income taxes	-	-	-	311	107	200	391	361	335	737	427	599	389	-1,682	426
Effective tax rate (%)	-	-	-
Net income	266	4,871	1,979	340	10	861	970	894	707	1,607	1,483	1,605	1,377	-3,288	2,011
Earnings per share	2.94	53.81	21.87	3.77	0.11	95.86	109.61	101.96	80.59	183.18	169.09	183.07	159.98	-384.95	235.63
Dividend per share	-	-	-	-	-	-	-	-	60	60	60	70	70	82	90